D
Denis Chem Lab Ltd
BSE:537536
Denis Chem Lab Ltd
BSE:537536
Price:
80.76
INR
-2.52%
Market Closed
Market Cap:
₹1.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
D
|
Denis Chem Lab Ltd
BSE:537536
|
IN |
|
V
|
VVMI La Hien Cement JSC
VN:CLH
|
VN |
|
H
|
Hon Hai Precision Industry Co Ltd
LSE:HHPD
|
TW |
|
Yageo Corp
TWSE:2327
|
TW |
|
POCO Holding Co Ltd
SZSE:300811
|
CN |
|
C
|
CPM Group Ltd
HKEX:1932
|
HK |
|
S
|
Showa Holdings Co Ltd
TSE:5103
|
JP |
|
A
|
Aimer Co Ltd
SSE:603511
|
CN |
|
Zhejiang Yonghe Refrigerant Co Ltd
SSE:605020
|
CN |
|
S
|
Sun International Ltd
XBER:RY1B
|
ZA |
|
P
|
PSI Software AG
OTC:PSSWF
|
DE |
|
G
|
G City Ltd
TASE:GCT
|
IL |
|
Japan Steel Works Ltd
TSE:5631
|
JP |
Multiples-Based Value
The Multiples-Based Value of one DENISCHEM stock under the Base Case scenario is hidden INR. Compared to the current market price of 80.76 INR, Denis Chem Lab Ltd is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
DENISCHEM Multiples-Based Value
LOCKED
Multiples Across Competitors
DENISCHEM Competitors Multiples
Denis Chem Lab Ltd Competitors
Denis Chem Lab Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
D
|
Denis Chem Lab Ltd
BSE:537536
|
1.1B INR | 0.6 | 12.9 | 4.9 | 8.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
855.1B USD | 13.1 | 41.4 | 28 | 29.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.7B USD | 6 | 27.3 | 17.5 | 22.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.6 | 11.6 | 13.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
229B GBP | 5.2 | 29.8 | 16.5 | 23.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
228.1B CHF | 5 | 20.3 | 12.6 | 16.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
291.8B USD | 4.5 | 16 | 9.9 | 12.1 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.7 | 11.3 | 8.3 | 9.7 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.6B USD | 2.5 | 19.9 | 7.7 | 10.2 | |
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
86.8B GBP | 2.7 | 15.2 | 8.2 | 10.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
